ArticleLife (Basel, Switzerland)2022

Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response-Data from the German HS Registry HSBest.

Natalia Kirsten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.